Sterne, Kessler, Goldstein & Fox has selected Byron Pickard to serve as the firm’s new managing director, marking the first ...

Pooled patients treated with TTI-101 demonstrated a 9.4% decrease from baseline in fibrosis score at week 12, compared to a 2.4% decrease for the ...

Tvardi Therapeutics, Inc. ("Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of ...

Women's nutrition needs change with age due to hormonal shifts. Doctors explain what women should eat at different life ...

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration ...

As the President reshapes the nation’s capital, the city’s arts community struggles to withstand an administration obsessed ...

Superionic water—the hot, black and strangely conductive form of ice that exists in the center of distant planets—was ...

A material that can switch its appearance, cephalopod-style, could have future applications in robotics or display technology ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...

Euro (EUR) appears to have entered a range-trading phase between 1.1695 and 1.1750. In the longer run, bias remains tilted to the downside, but EUR must close below 1.1680 before a move toward 1.1650 ...